Global Influenza Vaccine Market 2023-2027

Description

List of Tables

The influenza vaccine market is forecasted to grow by USD 2,933.88 mn during 2022-2027, accelerating at a CAGR of 6.89% during the forecast period. The report on the influenza vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence and incidence of influenza, rising awareness about influenza vaccination, and initiation of immunization programs and research activities.

Technavio's influenza vaccine market is segmented as below:

By Distribution Channel

Hospitals and pharmacies
Government and institutional
Others

By Type

Live attenuated influenza vaccines
Recombinant influenza vaccines

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the need for revaccination as one of the prime reasons driving the influenza vaccine market growth during the next few years. Also, the surge in the number of genetic characterization studies on the influenza virus and an increase in global travel will lead to sizable demand in the market.

The report on the influenza vaccine market covers the following areas:

Influenza vaccine market sizing
Influenza vaccine market forecast
Influenza vaccine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza vaccine market vendors that include Altimmune Inc., AstraZeneca PLC, Baxter International Inc., BioDiem Ltd, BiondVax Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., FluGen Inc., GlaxoSmithKline Plc, Mitsubishi Chemical Group Corp., Novavax Inc., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Shijiazhuang Yiling Pharmaceutical Co Ltd., SK Chemicals Co. Ltd., Vaccitech Plc, Vaxart Inc., and Vaxine Pty Ltd.. Also, the influenza vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73298

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global influenza vaccine market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global influenza vaccine market 2017 - 2021 ($ million)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospitals and pharmacies - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
6.4 Government and institutional - Market size and forecast 2022-2027
Exhibit 38: Chart on Government and institutional - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Government and institutional - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Government and institutional - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Government and institutional - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Live attenuated influenza vaccines - Market size and forecast 2022-2027
Exhibit 52: Chart on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
7.4 Recombinant influenza vaccines - Market size and forecast 2022-2027
Exhibit 56: Chart on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ million)
Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Altimmune Inc.
Exhibit 111: Altimmune Inc. - Overview
Exhibit 112: Altimmune Inc. - Product / Service
Exhibit 113: Altimmune Inc. - Key news
Exhibit 114: Altimmune Inc. - Key offerings
12.4 AstraZeneca PLC
Exhibit 115: AstraZeneca PLC - Overview
Exhibit 116: AstraZeneca PLC - Product / Service
Exhibit 117: AstraZeneca PLC - Key news
Exhibit 118: AstraZeneca PLC - Key offerings
12.5 Baxter International Inc.
Exhibit 119: Baxter International Inc. - Overview
Exhibit 120: Baxter International Inc. - Business segments
Exhibit 121: Baxter International Inc. - Key news
Exhibit 122: Baxter International Inc. - Key offerings
Exhibit 123: Baxter International Inc. - Segment focus
12.6 BiondVax Pharmaceuticals Ltd.
Exhibit 124: BiondVax Pharmaceuticals Ltd. - Overview
Exhibit 125: BiondVax Pharmaceuticals Ltd. - Product / Service
Exhibit 126: BiondVax Pharmaceuticals Ltd. - Key offerings
12.7 CSL Ltd.
Exhibit 127: CSL Ltd. - Overview
Exhibit 128: CSL Ltd. - Business segments
Exhibit 129: CSL Ltd. - Key news
Exhibit 130: CSL Ltd. - Key offerings
Exhibit 131: CSL Ltd. - Segment focus
12.8 FluGen Inc.
Exhibit 132: FluGen Inc. - Overview
Exhibit 133: FluGen Inc. - Product / Service
Exhibit 134: FluGen Inc. - Key offerings
12.9 GlaxoSmithKline Plc
Exhibit 135: GlaxoSmithKline Plc - Overview
Exhibit 136: GlaxoSmithKline Plc - Business segments
Exhibit 137: GlaxoSmithKline Plc - Key news
Exhibit 138: GlaxoSmithKline Plc - Key offerings
Exhibit 139: GlaxoSmithKline Plc - Segment focus
12.10 Mitsubishi Chemical Group Corp.
Exhibit 140: Mitsubishi Chemical Group Corp. - Overview
Exhibit 141: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 142: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 143: Mitsubishi Chemical Group Corp. - Segment focus
12.11 Novavax Inc.
Exhibit 144: Novavax Inc. - Overview
Exhibit 145: Novavax Inc. - Product / Service
Exhibit 146: Novavax Inc. - Key offerings
12.12 Pfizer Inc.
Exhibit 147: Pfizer Inc. - Overview
Exhibit 148: Pfizer Inc. - Product / Service
Exhibit 149: Pfizer Inc. - Key news
Exhibit 150: Pfizer Inc. - Key offerings
12.13 Sanofi SA
Exhibit 151: Sanofi SA - Overview
Exhibit 152: Sanofi SA - Business segments
Exhibit 153: Sanofi SA - Key news
Exhibit 154: Sanofi SA - Key offerings
Exhibit 155: Sanofi SA - Segment focus
12.14 Shijiazhuang Yiling Pharmaceutical Co Ltd.
Exhibit 156: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Overview
Exhibit 157: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Product / Service
Exhibit 158: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Key offerings
12.15 SK Chemicals Co. Ltd.
Exhibit 159: SK Chemicals Co. Ltd. - Overview
Exhibit 160: SK Chemicals Co. Ltd. - Business segments
Exhibit 161: SK Chemicals Co. Ltd. - Key offerings
Exhibit 162: SK Chemicals Co. Ltd. - Segment focus
12.16 Vaccitech Plc
Exhibit 163: Vaccitech Plc - Overview
Exhibit 164: Vaccitech Plc - Product / Service
Exhibit 165: Vaccitech Plc - Key offerings
12.17 Vaxart Inc.
Exhibit 166: Vaxart Inc. - Overview
Exhibit 167: Vaxart Inc. - Product / Service
Exhibit 168: Vaxart Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations